FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010018248> ?p ?o ?g. }

• W2010018248 endingPage "394" @default.
• W2010018248 startingPage "387" @default.
• W2010018248 abstract "Objectives The aims of this study were to evaluate in a canine model applicators designed for ablation of human benign prostatic hyperplasia (BPH) in vivo under magnetic resonance imaging (MRI) guidance, including magnetic resonance thermal imaging (MRTI), determine the ability of MRI techniques to visualize ablative changes in prostate, and evaluate the acute and longer term histologic appearances of prostate tissue ablated during these studies. Materials and Methods An MRI-compatible transurethral device incorporating a tubular transducer array with dual 120° sectors was used to ablate canine prostate tissue in vivo, in zones similar to regions of human BPH (enlarged transition zones). Magnetic resonance thermal imaging was used for monitoring of ablation in a 3-T environment, and postablation MRIs were performed to determine the visibility of ablated regions. Three canine prostates were ablated in acute studies, and 2 animals were rescanned before killing at 31 days postablation. Acute and chronic appearances of ablated prostate tissue were evaluated histologically and were correlated with the MRTI and postablation MRI scans. Results It was possible to ablate regions similar in size to enlarged transition zone in human BPH in 6 to 18 minutes. Regions of acute ablation showed a central “heat-fixed” region surrounded by a region of more obvious necrosis with complete disruption of tissue architecture. After 31 days, ablated regions demonstrated complete apparent resorption of ablated tissue with formation of cystic regions containing fluid. The inherent cooling of the urethra using the technique resulted in complete urethral preservation in all cases. Conclusions Prostatic ablation of zones of size and shape corresponding to human BPH is possible using appropriate transurethral applicators using MRTI, and ablated tissue may be depicted clearly in contrast-enhanced magnetic resonance images. The ability accurately to monitor prostate tissue heating, the apparent resorption of ablated regions over 1 month, and the inherent urethral preservation suggest that the magnetic resonance–guided techniques described are highly promising for the in vivo ablation of symptomatic human BPH." @default.
• W2010018248 created "2016-06-24" @default.
• W2010018248 creator A5007875006 @default.
• W2010018248 creator A5008058056 @default.
• W2010018248 creator A5024153496 @default.
• W2010018248 creator A5026303045 @default.
• W2010018248 creator A5032647737 @default.
• W2010018248 creator A5033518712 @default.
• W2010018248 creator A5036524420 @default.
• W2010018248 creator A5043272976 @default.
• W2010018248 creator A5064089475 @default.
• W2010018248 creator A5075025160 @default.
• W2010018248 creator A5088938146 @default.
• W2010018248 date "2013-06-01" @default.
• W2010018248 modified "2023-09-25" @default.
• W2010018248 title "Applicators for Magnetic Resonance–Guided Ultrasonic Ablation of Benign Prostatic Hyperplasia" @default.
• W2010018248 cites W1569018819 @default.
• W2010018248 cites W1595669926 @default.
• W2010018248 cites W171260885 @default.
• W2010018248 cites W184224827 @default.
• W2010018248 cites W1857205340 @default.
• W2010018248 cites W1973588264 @default.
• W2010018248 cites W1982311990 @default.
• W2010018248 cites W1986402691 @default.
• W2010018248 cites W1986439218 @default.
• W2010018248 cites W1988532997 @default.
• W2010018248 cites W2000968608 @default.
• W2010018248 cites W2003241238 @default.
• W2010018248 cites W2009054584 @default.
• W2010018248 cites W2016516406 @default.
• W2010018248 cites W2016779928 @default.
• W2010018248 cites W2017888684 @default.
• W2010018248 cites W2018310204 @default.
• W2010018248 cites W2035376883 @default.
• W2010018248 cites W2053540282 @default.
• W2010018248 cites W2059111072 @default.
• W2010018248 cites W2067182903 @default.
• W2010018248 cites W2069785779 @default.
• W2010018248 cites W2073175730 @default.
• W2010018248 cites W2076721801 @default.
• W2010018248 cites W2083184324 @default.
• W2010018248 cites W2086061853 @default.
• W2010018248 cites W2088961912 @default.
• W2010018248 cites W2104108179 @default.
• W2010018248 cites W2105308790 @default.
• W2010018248 cites W2105703325 @default.
• W2010018248 cites W2110394359 @default.
• W2010018248 cites W2110569728 @default.
• W2010018248 cites W2111039522 @default.
• W2010018248 cites W2136493228 @default.
• W2010018248 cites W2137617684 @default.
• W2010018248 cites W2145221548 @default.
• W2010018248 cites W2167244397 @default.
• W2010018248 doi "https://doi.org/10.1097/rli.0b013e31827fe91e" @default.
• W2010018248 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4045500" @default.
• W2010018248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23462673" @default.
• W2010018248 hasPublicationYear "2013" @default.
• W2010018248 type Work @default.
• W2010018248 sameAs 2010018248 @default.
• W2010018248 citedByCount "16" @default.
• W2010018248 countsByYear W20100182482013 @default.
• W2010018248 countsByYear W20100182482014 @default.
• W2010018248 countsByYear W20100182482015 @default.
• W2010018248 countsByYear W20100182482016 @default.
• W2010018248 countsByYear W20100182482017 @default.
• W2010018248 countsByYear W20100182482019 @default.
• W2010018248 countsByYear W20100182482020 @default.
• W2010018248 countsByYear W20100182482021 @default.
• W2010018248 crossrefType "journal-article" @default.
• W2010018248 hasAuthorship W2010018248A5007875006 @default.
• W2010018248 hasAuthorship W2010018248A5008058056 @default.
• W2010018248 hasAuthorship W2010018248A5024153496 @default.
• W2010018248 hasAuthorship W2010018248A5026303045 @default.
• W2010018248 hasAuthorship W2010018248A5032647737 @default.
• W2010018248 hasAuthorship W2010018248A5033518712 @default.
• W2010018248 hasAuthorship W2010018248A5036524420 @default.
• W2010018248 hasAuthorship W2010018248A5043272976 @default.
• W2010018248 hasAuthorship W2010018248A5064089475 @default.
• W2010018248 hasAuthorship W2010018248A5075025160 @default.
• W2010018248 hasAuthorship W2010018248A5088938146 @default.
• W2010018248 hasBestOaLocation W20100182482 @default.
• W2010018248 hasConcept C121608353 @default.
• W2010018248 hasConcept C126322002 @default.
• W2010018248 hasConcept C126838900 @default.
• W2010018248 hasConcept C136229726 @default.
• W2010018248 hasConcept C142724271 @default.
• W2010018248 hasConcept C143409427 @default.
• W2010018248 hasConcept C150903083 @default.
• W2010018248 hasConcept C192562407 @default.
• W2010018248 hasConcept C207001950 @default.
• W2010018248 hasConcept C2776235491 @default.
• W2010018248 hasConcept C2777562237 @default.
• W2010018248 hasConcept C2778902805 @default.
• W2010018248 hasConcept C71924100 @default.
• W2010018248 hasConcept C76856502 @default.
• W2010018248 hasConcept C86803240 @default.
• W2010018248 hasConceptScore W2010018248C121608353 @default.
• W2010018248 hasConceptScore W2010018248C126322002 @default.

• next